Clinical Trial Update: An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy [NA]

View source ↗

Summary

An open-label prospective study to evaluate the efficacy and safety of pegfilgrastim in patients with triple-negative breast cancer receiving AC chemotherapy af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Yonsei University | Conditions: Triple-Negative Breast Cancer | NA | Status: RECRUITING